Alimo Peptide
Finnrick has tested 8 samples from Alimo Peptide across 2 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Tirzepatide | 5 | 11 Jun 2025 | 11 May 2026 | |||||
| Retatrutide | 3 | 11 Jun 2025 | 13 Oct 2025 | |||||
The Alimo Peptide samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent Alimo Peptide tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 11 May 2026 | Tirzepatide | View | 30mg | (no batch claim) | 30.3mg | +1.0% | 99.90% | low | (no batch ID) | No Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 13 Oct 2025 | Retatrutide | View | 20mg | (no batch claim) | 23.7mg | +18.5% | 99.60% | n/a | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab G | Public | |
| 11 Aug 2025 | Tirzepatide | View | 60mg | 64.2mg | 62mg | -3.4% | 99.94% | n/a | T60-2025 | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 5 Aug 2025 | Tirzepatide | View | 60mg | (no batch claim) | 90mg | +50.0% | 99.64% | n/a | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 4 Aug 2025 | Retatrutide | View | 15mg | ⚠️ Sample does not contain Retatrutide | n/a | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | ||||
| 29 Jun 2025 | Tirzepatide | View | 30mg | (no batch claim) | 53.6mg | +78.7% | 99.71% | n/a | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab E | Public | |
| 11 Jun 2025 | Tirzepatide | View | 40mg | (no batch claim) | 39.5mg | -1.3% | 99.80% | n/a | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab E | Public | |
About Alimo Peptide Test Results From Finnrick
Alimo Peptide is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 2 products and 8 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud). Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Alimo Peptide Testing Activity & Score Summary
In the past 30 days, Finnrick has published no new test results for Alimo Peptide, and 1 in the past three months. The overall dataset includes 8 tested samples with an average score of 5.3/10 across all products.
Across 8 identity-tested samples, 88% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.8%. Approximately 100% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products:
- Tirzepatide (5 tests, 100% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 3.8 to 10.0 (average 6.7/10), suggesting significant batch-to-batch differences.